基于低剂量CT影像组学与深度学习特征的非小细胞肺癌远端转移计算机辅助诊断
本研究回顾性收集381例和前瞻性收集114例非小细胞肺癌患者,并纳入外院179例进行外部验证,开发影像组学与深度学习特征预测远端转移。影像组学特征在内、前瞻及外部验证的AUC分别为0.885、0.854、0.733,深度学习特征分别为0.893、0.786、0.780,提示基于低剂量CT的特征有潜力辅助肺癌筛查中的进一步诊断与治疗决策。
要点
- 低剂量CT影像组学与深度学习特征可用于预测非小细胞肺癌远端转移。
- 影像组学特征外部验证AUC为0.733,深度学习特征外部验证AUC为0.780。
- 可解释性分析显示两种特征均能识别肿瘤内部体素变异以辅助判断远端转移。
核心结论
- 基于低剂量CT的影像组学与深度学习特征在预测非小细胞肺癌远端转移方面表现出良好性能,并优于既往研究提出的方法;这些特征可能有助于改进肺癌筛查中进一步诊断检查与治疗策略。
研究设计与样本
- 研究为影像组学与深度学习特征开发及验证研究,回顾性收集381例、前瞻性收集114例非小细胞肺癌患者,并纳入外院179例进行外部验证,共674例经病理确诊,其中143例有远端转移;采用机器学习算法开发影像组学特征,采用神经架构搜索开发深度学习特征,以受试者工作特征曲线下面积(AUC)主要量化诊断效能。
诊断标准与关键数值
- 影像组学特征在内、前瞻及外部验证中的AUC分别为0.885、0.854、0.733。
- 深度学习特征在内、前瞻及外部验证中的AUC分别为0.893、0.786、0.780。
临床应用与阅片要点
- 作者认为基于低剂量CT的影像组学与深度学习特征可能有助于改进肺癌筛查中进一步诊断检查与治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to develop and validate radiomics and deep learning (DL) signatures for predicting distal metastasis (DM) of non-small cell lung cancer (NSCLC) in low-dose computed tomography (LDCT).
METHODS: Images and clinical data were retrospectively collected for 381 NSCLC patients and prospectively collected for 114 patients at the Fifth Affiliated Hospital of Sun Yat-Sen University. Additionally, we enrolled 179 patients from the Jiangmen Central Hospital to externally validate the signatures. Machine-learning algorithms were employed to develop radiomics signature while the DL signature was developed using neural architecture search. The diagnostic efficiency was primarily quantified with the area under receiver operating characteristic curve (AUC). We interpreted the reasoning process of the radiomics signature and DL signature by radiomics voxel mapping and attention weight tracking.
RESULTS: A total of 674 patients with pathologically-confirmed NSCLC were included from two institutions, with 143 of them having DM. The radiomics signature achieved AUCs of 0.885, 0.854, and 0.733 in the internal validation, prospective validation, and external validation while those for DL signature were 0.893, 0.786, and 0.780. The proposed signatures achieved a promising performance in predicting the DM of NSCLC and outperformed the approaches proposed in previous studies. Interpretability analysis revealed that both radiomics and DL signatures could detect the variations among voxels inside tumors, which helped in identifying the DM of NSCLC.
CONCLUSIONS: Our study demonstrates the potential of LDCT-based radiomics and DL signatures for predicting DM in NSCLC. These signatures could help improve lung cancer screening regarding further diagnostic tests and treatment strategies.
引用
- Song X, Duan X, He X, et al. Computer-aided diagnosis of distal metastasis in non-small cell lung cancer by low-dose CT based radiomics and deep learning signatures. Radiol Med. 2024. PMID: 38214839. doi:10.1007/s11547-024-01770-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。